LC-MS, liquid chromatography-mass spectrometry
Australia Clinical research on AOD-9604 has explored its potential to reduce fat deposits, particularly in cases of obesity, without causing potential side effects on blood sugar levels, insulin sensitivity, or muscle growth
TRIUMPH-4 Safety Signals Retatrutide's safety profile is still being established
GLP-1 medications consistently reduce inflammatory markers such as high-sensitivity C-reactive protein
In 2019, the California State Board of Pharmacy received a complaint that Empower was sending residents a vitamin C injectable that was a copy of an FDA approved medication and therefore not eligible for compounding, according to public pharmacy board documents
These companies have the technical capability to reproduce complex biologics at scale